Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
21.10
-0.53 (-2.45%)
At close: Nov 2, 2026, 4:00 PM EST
21.25
+0.15 (0.71%)
After-hours: Nov 2, 2026, 7:30 PM EST

Legend Biotech Revenue

Legend Biotech had revenue of $387.50M in the quarter ending June 30, 2026, with 51.90% growth. This brings the company's total for the last twelve months to $1.27B, up 59.54% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth. That makes Legend Biotech the 6,632nd largest company in the world by revenue and 1,627th in the United States.

Revenue (ttm)
$1.27B
Revenue Growth
+59.54%
P/S Ratio
3.22
Revenue / Employee
$428,803
Employees
3,200
Market Cap
4.09B

Revenue Chart

Chart

Revenue by Segment

By Segment

Chart
  • Collaboration 944.80M 91.8%
  • License 83.80M 8.1%
  • Other Service 300.00K 0.0%

By Geography

Chart
  • United States of America 803.60M 78.1%
  • Europe 198.70M 19.3%
  • China 26.60M 2.6%
Fiscal year ended Dec 31, 2025 See the full Legend Biotech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M15.02M25.04%
Dec 31, 201959.98M10.85M22.08%
Dec 31, 201849.13M25.54M108.24%
Dec 31, 201723.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Acadia Pharmaceuticals1.14B
Travere Therapeutics591.33M
Arcutis Biotherapeutics463.98M
Iovance Biotherapeutics324.97M
AbCellera Biologics66.17M
Tango Therapeutics53.81M
Relay Therapeutics10.35M
Xenon Pharmaceuticals7.50M
Revenue Rankings

LEGN News

More News